Stefano Cascinu

28.7k total citations · 4 hit papers
648 papers, 18.3k citations indexed

About

Stefano Cascinu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Stefano Cascinu has authored 648 papers receiving a total of 18.3k indexed citations (citations by other indexed papers that have themselves been cited), including 444 papers in Oncology, 308 papers in Pulmonary and Respiratory Medicine and 141 papers in Cancer Research. Recurrent topics in Stefano Cascinu's work include Colorectal Cancer Treatments and Studies (221 papers), Gastric Cancer Management and Outcomes (149 papers) and Pancreatic and Hepatic Oncology Research (92 papers). Stefano Cascinu is often cited by papers focused on Colorectal Cancer Treatments and Studies (221 papers), Gastric Cancer Management and Outcomes (149 papers) and Pancreatic and Hepatic Oncology Research (92 papers). Stefano Cascinu collaborates with scholars based in Italy, United States and United Kingdom. Stefano Cascinu's co-authors include Rossana Berardi, Mario Scartozzi, Giuseppina Catalano, Matteo Santoni, Roberto Labianca, Francesco Graziano, Vincenzo Catalano, Riccardo Giampieri, Eric Van Cutsem and Paolo Giordani and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Stefano Cascinu

630 papers receiving 17.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status

2011 1.4k citations Eric Van Cutsem, Claus-Henning Köhne et al. Journal of Clinical Oncology profile →
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

2022 646 citations Stefano Cascinu et al. Annals of Oncology profile →
Addressing the challenges of pancreatic cancer: Future directions for improving outcomes

2014 386 citations Stefano Cascinu et al. profile →
Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study

2014 339 citations Stefano Cascinu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stefano Cascinu Italy	63	11.2k	7.3k	4.2k	3.4k	3.4k	648	18.3k
Ian Chau United Kingdom	56	13.1k 1.2×	7.2k 1.0×	2.6k 0.6×	5.4k 1.6×	2.4k 0.7×	473	18.8k
Michael J. Overman United States	58	11.2k 1.0×	3.9k 0.5×	2.6k 0.6×	3.9k 1.1×	3.1k 0.9×	447	16.5k
Patrick Schöffski Belgium	68	9.6k 0.9×	9.5k 1.3×	4.8k 1.2×	3.2k 0.9×	2.2k 0.7×	510	19.4k
Filippo de Braud Italy	74	17.9k 1.6×	8.8k 1.2×	5.7k 1.4×	5.6k 1.7×	3.7k 1.1×	754	26.7k
Jordan Berlin United States	60	15.3k 1.4×	6.3k 0.9×	6.6k 1.6×	3.4k 1.0×	5.0k 1.5×	357	22.9k
Timothy Price Australia	48	10.7k 1.0×	5.0k 0.7×	2.8k 0.7×	2.8k 0.8×	2.3k 0.7×	476	14.8k
Manish A. Shah United States	67	8.9k 0.8×	8.0k 1.1×	4.1k 1.0×	5.2k 1.5×	2.0k 0.6×	336	17.3k
Andrés Cervantes Spain	68	18.1k 1.6×	9.4k 1.3×	4.2k 1.0×	8.4k 2.5×	3.3k 1.0×	468	27.8k
Hye Seung Lee South Korea	66	5.9k 0.5×	5.0k 0.7×	4.0k 0.9×	5.5k 1.6×	1.8k 0.5×	452	16.1k
Dirk Arnold Germany	47	11.4k 1.0×	6.7k 0.9×	1.6k 0.4×	6.9k 2.0×	1.8k 0.5×	271	17.0k

Countries citing papers authored by Stefano Cascinu

Since Specialization

Citations

This map shows the geographic impact of Stefano Cascinu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefano Cascinu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefano Cascinu more than expected).

Fields of papers citing papers by Stefano Cascinu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefano Cascinu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefano Cascinu. The network helps show where Stefano Cascinu may publish in the future.

Co-authorship network of co-authors of Stefano Cascinu

This figure shows the co-authorship network connecting the top 25 collaborators of Stefano Cascinu. A scholar is included among the top collaborators of Stefano Cascinu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefano Cascinu. Stefano Cascinu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Porcu, Luca, Leone Giordano, Stefano Cascinu, et al.. (2023). Emergency Department Visits among Cancer Patients during SARS-CoV-2 Pandemic. Cancers. 15(4). 1240–1240.

Arbore, Giuseppina, Luca Albarello, Gabriele Bucci, et al.. (2023). Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma. Cancer Research. 83(17). 2873–2888. 10 indexed citations

Rimini, Margherita, Eleonora Loi, Valentina Burgio, et al.. (2022). P-126 Clustering analysis identified three IDH1-mutated intrahepatic cholangiocarcinoma's clusters with prognostic significance. Annals of Oncology. 33. S295–S295. 2 indexed citations

Ratti, Francesca, Federica Cipriani, Guido Fiorentini, et al.. (2021). Evolution of Surgical Treatment of Colorectal Liver Metastases in the Real World: Single Center Experience in 1212 Cases. Cancers. 13(5). 1178–1178. 6 indexed citations

Sommariva, Antonio, Luca Ansaloni, Gian Luca Baiocchi, et al.. (2020). Diagnostic and therapeutic algorithm for colorectal peritoneal metastases. A consensus of the peritoneal surface malignancies onco-team of the Italian society of surgical oncology. European Journal of Surgical Oncology. 47(1). 164–171. 3 indexed citations

Omarini, Claudia, Giorgia Guaitoli, Stefania Pipitone, et al.. (2018). Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going. Cancer Management and Research. Volume 10. 91–103. 56 indexed citations

Ballatore, Z., Mirco Pistelli, Nicola Battelli, et al.. (2016). Everolimus and exemestane in long survival hormone receptor positive male breast cancer: case report. BMC Research Notes. 9(1). 497–497. 10 indexed citations

Santoni, Matteo, Alessandro Conti, Francesco Piva, et al.. (2015). Role of STAT3 pathway in genitourinary tumors. PMC. 1 indexed citations

Bittoni, Alessandro, Kalliopi Andrikou, Andrea Lanese, et al.. (2015). Trattamento del carcinoma del pancreas. Attualità e prospettive. Recenti Progressi in Medicina. 106(5). 208–16. 2 indexed citations

10.

Aprile, Giuseppe, Riccardo Giampieri, Marta Bonotto, et al.. (2014). The challenge of targeted therapies for gastric cancer patients: the beginning of a long journey. Expert Opinion on Investigational Drugs. 23(7). 925–942. 25 indexed citations

11.

Bittoni, Alessandro, Mario Scartozzi, Riccardo Giampieri, et al.. (2013). Clinical Evidence for Three Distinct Gastric Cancer Subtypes: Time for a New Approach. PLoS ONE. 8(11). e78544–e78544. 56 indexed citations

12.

Brunelli, Alessandro, Cecilia Pompili, Rossana Berardi, et al.. (2012). Performance at Preoperative Stair-Climbing Test Is Associated With Prognosis After Pulmonary Resection in Stage I Non-Small Cell Lung Cancer. The Annals of Thoracic Surgery. 93(6). 1796–1800. 42 indexed citations

13.

Cutsem, Eric Van, Claus-Henning Köhne, István Láng, et al.. (2011). Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status. Journal of Clinical Oncology. 29(15). 2011–2019. 1441 indexed citations breakdown →

14.

Cascinu, Stefano, et al.. (2011). 転移性大腸癌のファーストライン治療としてのセツキシマブ+イリノテカン,フルオロウラシルおよびロイコボリン: 腫瘍KRASとBRAF突然変異ステータスによる全生存率分析の最新版. Journal of Clinical Oncology. 29(15). 2011–2019. 61 indexed citations

15.

Guarneri, Valentina, Antonio Frassoldati, Paolo Bruzzi, et al.. (2008). Multicentric, Randomized Phase III Trial of Two Different Adjuvant Chemotherapy Regimens plus Three Versus Twelve Months of Trastuzumab in Patients with HER2-Positive Breast Cancer (Short-HER Trial; NCT00629278). Clinical Breast Cancer. 8(5). 453–456. 40 indexed citations

16.

Sartore‐Bianchi, Andrea, Mauro Moroni, Silvio Veronese, et al.. (2007). Epidermal Growth Factor Receptor Gene Copy Number and Clinical Outcome of Metastatic Colorectal Cancer Treated With Panitumumab. Journal of Clinical Oncology. 25(22). 3238–3245. 264 indexed citations

17.

Musolino, Antonino, Maria Michiara, Maria Angela Bella, et al.. (2005). Molecular Profile and Clinical Variables in Brca1-Positive Breast Cancers. A Population-Based Study. Tumori Journal. 91(6). 505–512. 14 indexed citations

18.

Aragona, Marcello, D Romeo, Giuseppe Pastura, et al.. (2001). Nerve Growth Factor Receptor Immunoreactivity in Breast Cancer Patients. Cancer Investigation. 19(7). 692–697. 20 indexed citations

19.

Cascinu, Stefano, Frank M. Graziano, Paolo Alessandroni, et al.. (1998). Different doses of pamidronate in patients with painful osteolytic bone metastases. Supportive Care in Cancer. 6(2). 139–143. 27 indexed citations

20.

Cascinu, Stefano, et al.. (1997). Tumor Markers in the Diagnosis of Malignant Serous Effusions. American Journal of Clinical Oncology. 20(3). 247–250. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact